Is a Novel Transthyretin Gene Mutation Associated With Cerebral Amyloid Angiopathy?
European Journal of Neurology · 2025-08 · 32 (8)
DOI: 10.1111/ene.70217 ↗Kurz gefasst
Fallbericht in der Zeitschrift European Journal of Neurology, online erschienen am 25.08.2025. Verfasst von Strazzabosco Camilla und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cerebrovascular Unit, Fondazione I.R.C.C.S. Istituto Neurologico "Carlo Besta", Milan, Italy. Hauptthemen laut MEDLINE: Cerebral Amyloid Angiopathy, Prealbumin, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
To report a case of a novel variant of the TTR gene associated with Cerebral Amyloid Angiopathy (CAA), thereby expanding the spectrum of TTR‐related amyloidosis.
Methods
A 56‐year‐old man presented with a history of right fronto‐parietal intracerebral haemorrhage and recurrent transient episodes of right arm paraesthesia. Based on clinical and radiological presentation, a probable CAA diagnosis was established according to Boston Criteria 2.0. The patient underwent an extensive evaluation, including genetic testing, cerebrospinal fluid (CSF) analysis and amyloid PET imaging.
Results
CSF analysis and amyloid PET imaging corroborated CAA diagnosis. Genetic testing identified an undescribed heterozygous c.124G > A (p.Gly42Ser) TTR variant, absent from population databases, within a region known for pathogenic mutations. Family genetic testing revealed the same mutation in the patient's father, who had a history of cerebral haemorrhage.
Discussion
To our knowledge, this case represents one of the first documented examples of a TTR gene variant exclusively associated with CAA, in the absence of systemic amyloidosis. These findings suggest the existence of TTR variants that may result in a brain‐restricted amyloid pathology. Genetic screening for TTR mutations should be considered in familial cases of CAA to refine diagnostic accuracy and guide clinical management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cerebrovascular Unit, Fondazione I.R.C.C.S. Istituto Neurologico "Carlo Besta", Milan, Italy.
- Unit of Medical Genetics and Neurogenetics, Fondazione I.R.C.C.S. Istituto Neurologico "Carlo Besta", Milan, Italy.
ORCID-Profile: Strazzabosco Camilla, Marinoni Giulia, Storti Benedetta, Gatti Laura, Bersano Anna
Zitieren
APA
Camilla, S., Giulia, M., Benedetta, S., Francesca, B., Stefania, M., Giuliana, P., Gemma, G., Laura, G., & Anna, B. (2025). Is a Novel Transthyretin Gene Mutation Associated With Cerebral Amyloid Angiopathy?. European Journal of Neurology, 32(8). https://doi.org/10.1111/ene.70217
Vancouver
Camilla S, Giulia M, Benedetta S, Francesca B, Stefania M, Giuliana P, et al. Is a Novel Transthyretin Gene Mutation Associated With Cerebral Amyloid Angiopathy?. European Journal of Neurology. 2025;32(8). doi:10.1111/ene.70217
BibTeX
@article{Camilla2025,
author = {Camilla, Strazzabosco and Giulia, Marinoni and Benedetta, Storti and Francesca, Balistreri and Stefania, Magri and Giuliana, Pollaci and Gemma, Gorla and Laura, Gatti and Anna, Bersano},
title = {Is a Novel Transthyretin Gene Mutation Associated With Cerebral Amyloid Angiopathy?},
journal = {European Journal of Neurology},
year = {2025},
volume = {32},
number = {8},
doi = {10.1111/ene.70217}
}
EUVIMED